Divi’s Laboratories

Hello,
My first post on ValuePickr after almost 3-4 years of scanning and leveraging your inputs for my research…

I’ve read the thread here quite extensively and feel I understand the business (and the reason for its high valuations) a lot better than before. One question I still have though is this – what does Divi’s competitive set look like domestically and internationally?

It seems like the major pharma players of the world and India – BASF, Teva, Cipla, Dr Reddy’s, Sun etc. – are all major API producers and therefore in direct competition with Divi.

Are there any reports which specify Divi’s competitors by product segment.

I’m still having a hard time computing the inherent competitive advantage Divi’s enjoys relative to other large pharma and API manufacturers of the world. Other Indian players will have the same input cost advantages Divi’s does, while the global guys will have scale advantages greater than Divi’s.

Inputs here would be much appreciated.